BRIEF published on 05/07/2024 at 21:05, 1 year 8 months ago Le gant « Ove » : le cadeau idéal pour la cuisine et les grillades saisonnières Idées De Cadeau Le Gant 'Ove' Protection Contre La Chaleur Les Essentiels Du Grill Saison Du Barbecue
BRIEF published on 05/07/2024 at 20:40, 1 year 8 months ago ALTAREIT annonce les derniers chiffres de son capital social Droits De Vote Franchissement De Seuil Capital Social ALTAREIT Actions
BRIEF published on 05/07/2024 at 20:40, 1 year 8 months ago ALTAREIT announces the latest figures of its share capital Share Capital Voting Rights ALTAREIT Actions Threshold Crossing
BRIEF published on 05/07/2024 at 20:35, 1 year 8 months ago ALTAREIT publie son rapport d'opérations sur titres propres pour avril 2024 ALTAREIT Kepler Cheuvreux Actions Rapport Mensuel Transactions Boursières
BRIEF published on 05/07/2024 at 20:35, 1 year 8 months ago ALTAREIT publishes its own securities transactions report for April 2024 ALTAREIT Kepler Cheuvreux Actions Monthly Report Stock Transactions
BRIEF published on 05/07/2024 at 20:35, 1 year 8 months ago EXEL Industries détaille ses droits de vote et parts sociales au 30 avril 2024 Réglementation AMF EXEL Industries Droits De Vote EXEL Capitale Sociale Actions EXEL Industries
BRIEF published on 05/07/2024 at 20:35, 1 year 8 months ago EXEL Industries details its voting rights and shares as of April 30, 2024 AMF Regulations EXEL Industries EXEL Voting Rights Social Capital EXEL Industries Shares
BRIEF published on 05/07/2024 at 20:31, 1 year 8 months ago Biotest AG: Dividend Approval at Annual General Meeting Annual General Meeting Shareholder Approval Dividend Distribution Preference Shares Biotest AG
BRIEF published on 05/07/2024 at 20:31, 1 year 8 months ago Biotest AG : approbation du dividende lors de l'assemblée générale annuelle Assemblée Générale Annuelle Approbation Des Actionnaires Répartition Des Dividendes Partage De Préférence Biotest SA
BRIEF published on 05/07/2024 at 20:28, 1 year 8 months ago Altarea annonce ses opérations sur titres propres d'avril 2024 Actions Propres Contrat De Liquidité Altarea Kepler Cheuvreux Rapport Financier
Published on 01/20/2026 at 19:50, 15 minutes ago Taranis Expands Silver Cup Mining District Holdings to Over 6,000 Ha. in One of British Columbia's Oldest Silver and Gold Mining Districts
Published on 01/20/2026 at 18:45, 1 hour 20 minutes ago Totec Resources Announces Closing of Qualifying Transaction and Anticipated Trading Date
Published on 01/20/2026 at 15:45, 4 hours 20 minutes ago Caldwell Announces New Sponsorship on Canada's Outstanding CEO of the Year(R)
Published on 01/20/2026 at 15:00, 5 hours 5 minutes ago Pivotree Partners with OroCommerce to Deliver Unmatched B2B eCommerce Powered by Mastered Data
Published on 01/20/2026 at 14:30, 5 hours 35 minutes ago Karbon-X Secures up to $25 Million in Strategic Financing to Accelerate Growth and Expand Global Climate Solutions Platform
Published on 01/20/2026 at 19:19, 45 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares – conclusion and extension of buyback programme
Published on 01/20/2026 at 18:05, 2 hours ago PRC-Saltillo Announces Acquisition of Therapy Box® Apps, Enhancing AAC Communication Options Worldwide
Published on 01/20/2026 at 18:05, 2 hours ago Tournant politique urgemment nécessaire pour la mobilité automobile en Suisse
Published on 01/20/2026 at 17:40, 2 hours 25 minutes ago UV GERMI: Chiffre d’affaires annuel 2025 de 6,8 M€
Published on 01/20/2026 at 16:15, 3 hours 50 minutes ago Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy
Published on 01/20/2026 at 17:59, 2 hours 6 minutes ago Statement of transactions in own shares from January 14, 2026 to January 16, 2026
Published on 01/20/2026 at 17:59, 2 hours 6 minutes ago Déclaration des transactions sur actions propres réalisées du 14/01/2026 au 16/01/2026
Published on 01/20/2026 at 17:45, 2 hours 20 minutes ago Evolution au sein de la direction générale de Baikowski®
Published on 01/20/2026 at 07:30, 12 hours 35 minutes ago Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling
